We are live on
!
Find out more
Fate Therapeutics
FATE
FATE
250 hedge funds and large institutions have $3.92B invested in Fate Therapeutics in 2022 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 101 increasing their positions, 72 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
68% more call options, than puts
Call options by funds: $9.7M | Put options by funds: $5.77M
40% more repeat investments, than reductions
Existing positions increased: 101 | Existing positions reduced: 72
11% more funds holding in top 10
Funds holding in top 10: 9 → 10 (+1)
3.47% more ownership
Funds ownership: 101.46% → 104.93% (+3.5%)
6% more first-time investments, than exits
New positions opened: 36 | Existing positions closed: 34
0% more funds holding
Funds holding: 250 → 250 (0)
31% less capital invested
Capital invested by funds: $5.66B → $3.92B (-$1.74B)
Holders
250
Holders Change
–
Holders Change %
0%
% of All Funds
3.94%
Holding in Top 10
10
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+11.11%
% of All Funds
0.16%
New
36
Increased
101
Reduced
72
Closed
34
Calls
$9.7M
Puts
$5.77M
Net Calls
+$3.92M
Net Calls Change
-$4.31M
Top Buyers
Top Sellers
| 1 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$28.1M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$17.1M |
| 3 |
Morgan Stanley
New York
|
-$15.5M |
| 4 |
SG Americas Securities
New York
|
-$12.2M |
| 5 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
-$8.98M |
